GQ Life Sciences
The company exited the NGS whole-genome analysis market a few years ago and is now focused on building a business around its core IP search technology.
Robert Hoyt has joined GenomeQuest's board of directors
Hoyt is currently Eximo's chief operating officer. Prior to that, he was the general manager of Endeca Technologies which sold to Oracle in 2011.
This week, GenomeQuest launched a new Intellectual Property Management module for its software that lets customers manage their sequence IP.
Software vendors attempting to tap into the nascent clinical sequencing market are taking steps to ensure that their offerings toe the lines set by federal agencies to ensure the privacy and security of patient information.
GenomeQuest has completed an integration agreement with online information services firm Questel that allows researchers to review biological sequence patents from GenomeQuest's GQ-IP system via Questel's Orbit platform, an IP da
Mar 30, 2012
Jan 11, 2012
Dec 22, 2011
Oct 26, 2011
People in the News: Oct 26, 2011
Premium
Oct 25, 2011
People in the News: Oct 25, 2011
Premium
Oct 21, 2011
Oct 12, 2011
Jun 21, 2011
Jun 17, 2011
Jun 15, 2011